Home > Insider Trading > Filing (0001354488-17-000035)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001316	Tg Therapeutics Inc.	TGTX	Pharmaceutical Preparations (2834)	363898269

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1538845	A Sean Power	2 Gansevoort St 9Th Floor New York NY 10014	Cfo, Secretary And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-12-30	100,000	$0.00	516,256	No	4	A	Direct
Common Stock	Disposition	2017-01-04	8,816	$4.55	507,440	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Reflects a grant of restricted shares that will vest according to the following schedule: 17.5% on January 1, 2018; 17.5% on January 1, 2019; 35% on the later to occur of: (a) the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2016 and (b) June 30, 2019; and 30% on performance based thresholds associated with the Company?s clinical programs.
Includes shares of restricted Common Stock, which vest over various time periods.
In connection with the vesting of 15,000 shares on January 1, 2017, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average sales price.